Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.2600
-0.0150 (-5.45%)
Mar 31, 2026, 4:10 PM AEST
ASX:PIQ Market Cap
ASX:PIQ has a market cap or net worth of 42.95 million as of March 31, 2026. Its market cap has decreased by -33.09% in one year.
Market Cap
42.95M
Enterprise Value
35.49M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since April 16, 2015, ASX:PIQ's market cap has increased from 11.39M to 42.95M, an increase of 277.23%. That is a compound annual growth rate of 12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 45.43M | -57.65% |
| Dec 31, 2025 | 107.27M | 2.36% |
| Dec 31, 2024 | 104.80M | -4.28% |
| Dec 29, 2023 | 109.49M | -0.29% |
| Dec 30, 2022 | 109.81M | -14.46% |
| Dec 31, 2021 | 128.37M | 53.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 72.71M |
| Cynata Therapeutics | 71.24M |
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Neurizon Therapeutics | 56.65M |
| Prescient Therapeutics | 55.73M |
| Imugene | 51.77M |
| Entropy Neurodynamics | 48.52M |